+1 (502) 904-2126   One Westbrook Corporate Center, Suite 300, Westchester, IL 60154, USA   Site Map
ISSN: 2574 -1241

Impact Factor : 0.548

  Submit Manuscript

Mini ReviewOpen Access

Current Review; Biomarkers in Diagnosing Periprosthetic Joint Infection

Volume 1 - Issue 5

George N. Guild III MD, *Alisina Shahi MD and Thomas L. Bradbury MD

  • Author Information Open or Close
    • Orthopaedic department at Emory University School of Medicine, USA

    *Corresponding author: Alisina Shahi MD, Clinical Research Department, Rothman Institute at Thomas Jefferson University, Sheridan Building, Suite 1000, 125 South 9th Street, Philadelphia, PA 19107, USA

Received: October 14, 2017;   Published: October 20, 2017

DOI: 10.26717/BJSTR.2017.01.000453

Full Text PDF

To view the Full Article   Peer-reviewed Article PDF


Periprosthetic joint infection (PJI) is one of the most dreaded complications after total joint arthroplasty [1]. There is no gold standard for diagnosing PJI, hence, a clinician who encounters a suspected PJI case, ought to use a combination of tests. All of which, besides their expense can be invasive and even this can’t provide 100% accuracy [2]. Several biomarkers have been introduced that are potentially reliable tools for diagnosing PJI [3]. In this article, we aimed to review the current diagnostic measures of PJI with a special focus on molecular biomarkers.

Mini Review| Synovial Fluid Biomarkers| Serum Biomarkers| References|